Zenas BioPharma, Inc. (ZBIO)
25.28
+0.02
(+0.08%)
USD |
NASDAQ |
Mar 06, 16:00
25.32
+0.04
(+0.14%)
Pre-Market: 20:00
Zenas BioPharma Total Liabilities (Quarterly) : 125.59M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 81.93B |
| Johnson & Johnson | 117.67B |
| Eli Lilly & Co. | 85.94B |
| XOMA Royalty Corp. | 155.19M |
| CorMedix, Inc. | 420.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 322.02M |
| Shareholders Equity (Quarterly) | 196.43M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 5.659 |
| Net Debt Paydown Yield | -0.01% |